Neoleukin Therapeutics, Inc.
NASDAQ:NLTX
3.49 (USD) • At close December 18, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0.006 | 0 | 0 | 0.451 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | -25 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 3.418 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -3.418 | 0 | 0 | 0 | 0 | 0.006 | 0.006 | 0 | 0 | 0.451 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | -25 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.617 | -0.426 | 7.69 | 10.001 | 9.471 | 10.956 | 10.701 | 9.76 | 9.896 | 9.824 | 9.707 | 7.787 | 6.216 | 4.843 | 5.498 | 4.888 | 1.42 | -1.995 | 0.104 | 2.572 | 10.713 | 17.996 | 10.508 | 11.559 | 8.456 | 10.475 | 5.777 | 8.132 | 6.134 | 9.235 | 4.881 | 3.926 | 3.687 | 3.619 | 4.567 | 6.326 | 5.323 | 4.551 | 1.88 | 2.692 | 3.027 | 1.247 | 0.573 |
| General & Administrative Expenses
| 4.952 | 3.492 | 4.027 | 4.25 | 4.138 | 4.915 | 4.664 | 5.414 | 5.556 | 5.3 | 5.241 | 4.851 | 3.86 | 4.926 | 3.573 | 3.468 | 10.38 | 2.423 | 2.555 | 2.728 | 4.484 | 4.314 | 4.309 | 4.973 | 3.614 | 3.52 | 2.745 | 3.331 | 2.149 | 1.83 | 1.953 | 1.667 | 1.23 | 1.173 | 1.472 | 1.494 | 0.987 | 1.081 | 0.735 | 0.691 | 0.39 | 0.37 | 0.424 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| SG&A
| 4.952 | 3.492 | 4.027 | 4.25 | 4.138 | 4.915 | 4.664 | 5.414 | 5.556 | 5.3 | 5.241 | 4.851 | 3.86 | 4.926 | 3.573 | 3.468 | 10.38 | 2.423 | 2.555 | 2.728 | 4.484 | 4.314 | 4.309 | 4.973 | 3.614 | 3.52 | 2.745 | 3.331 | 2.149 | 1.83 | 1.953 | 1.667 | 1.23 | 1.173 | 1.472 | 1.494 | 0.987 | 1.081 | 0.735 | 0.691 | 0.39 | 0.37 | 0.424 |
| Other Expenses
| 0 | 0 | -0.014 | -0.002 | -0.023 | -0.016 | 0 | 0 | 0 | -0.011 | 0 | -0.001 | -0.004 | -0.019 | -0.02 | 0.002 | -0.009 | 0 | -0.001 | -0.012 | -0.262 | -0.118 | -0.053 | -0.003 | -0.007 | -0.009 | -0.02 | -0.016 | -0.012 | 0.007 | -0.022 | -0.004 | -0.038 | 0.034 | -0.36 | -0.26 | -0.001 | 0.196 | 0 | 0 | 0.142 | -0.021 | 0 |
| Operating Expenses
| 5.569 | 3.066 | 11.717 | 14.251 | 13.609 | 15.871 | 15.365 | 15.174 | 15.452 | 15.124 | 14.948 | 12.638 | 10.076 | 9.769 | 9.071 | 8.356 | 11.8 | 0.428 | 2.659 | 5.3 | 15.197 | 22.31 | 14.817 | 16.532 | 12.07 | 13.995 | 8.522 | 11.463 | 8.283 | 11.065 | 6.834 | 5.593 | 4.917 | 4.792 | 6.039 | 7.819 | 6.31 | 5.632 | 2.614 | 3.443 | 3.417 | 1.617 | 0.997 |
| Operating Income
| -5.569 | -3.066 | -15.135 | -14.251 | -13.609 | -15.871 | -15.366 | -15.167 | -15.446 | -15.129 | -14.95 | -54.818 | 2.25 | -9.746 | -8.642 | -8.356 | -59.516 | -0.428 | -2.659 | -5.3 | -15.197 | 2.69 | -14.817 | -16.532 | -12.07 | -13.995 | -8.522 | -11.463 | -8.283 | -11.065 | -6.834 | -5.593 | -4.917 | -4.792 | -6.039 | -8.088 | -6.282 | -5.422 | -3.774 | -3.443 | -3.371 | -0.81 | -1.008 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,527.833 | -2,574.333 | 0 | 0 | -121.548 | 2,250 | 0 | 0 | 0 | 0 | 0 | 0 | 0.212 | 0 | 0.108 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.043 | 0.981 | 0.931 | 0.834 | 0.537 | 0.183 | 0.015 | 0.001 | 0 | 0 | 0 | -28.778 | 7.826 | 0 | 0.444 | 0.255 | 0.384 | 0.427 | 0.451 | 0.413 | 0.204 | 0.228 | 0.194 | -0.419 | 0.237 | 0.229 | 0.206 | -0.198 | 0.137 | 0.164 | 0.123 | -0.052 | -0.118 | 0.042 | -0.373 | -0.012 | 0.027 | -0.002 | -0.454 | -0.097 | -0.002 | 0.946 | -0.002 |
| Income Before Tax
| -4.526 | -2.085 | -14.204 | -13.445 | -13.072 | -15.688 | -15.351 | -15.167 | -15.446 | -15.129 | -14.95 | -12.64 | -2.249 | -9.746 | -8.642 | -8.101 | -59.132 | -0.001 | -2.208 | -4.887 | -14.993 | 2.918 | -14.623 | -16.268 | -11.833 | -13.766 | -8.316 | -11.244 | -8.146 | -10.901 | -6.711 | -5.663 | -5.035 | -4.75 | -6.412 | -8.09 | -6.284 | -5.425 | -4.228 | -3.54 | -3.373 | -0.812 | -1.01 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,527.833 | -2,574.333 | 0 | 0 | -28.027 | -2,249 | 0 | 0 | 0 | 0 | 0 | 0 | 0.195 | 0 | 0.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 5.905 | -0.806 | -0.537 | -0.382 | 0.013 | -0.005 | -0.006 | -0.005 | -0.003 | -0.003 | -0.007 | -0.047 | -0.434 | -0.255 | -0.384 | -0.427 | -0.451 | -0.413 | -0.204 | -0.228 | -0.194 | -0.264 | -0.237 | -0.229 | -0.206 | -0.219 | -0.137 | -0.164 | -0.123 | -0.014 | 0.114 | -0.047 | 0.367 | 0.003 | -0 | 0.002 | 0.454 | 0.097 | -0.005 | 0.002 | 0.002 |
| Net Income
| -4.526 | -2.085 | -20.109 | -12.639 | -12.535 | -15.306 | -15.364 | -15.167 | -15.446 | -15.129 | -14.95 | -12.64 | -2.249 | -9.746 | -8.642 | -8.101 | -59.132 | -0.001 | -2.208 | -4.887 | -14.993 | 2.918 | -14.623 | -16.268 | -11.833 | -13.766 | -8.316 | -11.244 | -8.146 | -10.901 | -6.711 | -5.663 | -5.035 | -4.75 | -6.412 | -8.09 | -6.284 | -5.425 | -4.022 | 0.361 | -4.72 | -2.382 | -2.559 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,527.833 | -2,574.333 | 0 | 0 | -28.027 | -2,249 | 0 | 0 | 0 | 0 | 0 | 0 | 0.195 | 0 | 0.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.41 | -0.19 | -1.81 | -0.23 | -1.13 | -0.28 | -0.28 | -0.28 | -0.28 | -0.27 | -0.27 | -0.23 | -0.042 | -0.2 | -0.18 | -0.16 | -2.26 | 0 | -0.094 | -0.21 | -0.64 | 0.12 | -0.62 | -0.69 | -0.5 | -0.59 | -0.36 | -0.48 | -0.46 | -0.63 | -0.39 | -0.33 | -0.43 | -0.44 | -0.6 | -0.76 | -0.59 | -0.51 | -1.28 | -0.62 | -0.81 | -0.41 | -0.44 |
| EPS Diluted
| -0.41 | -0.19 | -1.81 | -0.23 | -1.13 | -0.28 | -0.28 | -0.28 | -0.28 | -0.27 | -0.27 | -0.23 | -0.042 | -0.2 | -0.18 | -0.16 | -2.26 | 0 | -0.094 | -0.21 | -0.64 | 0.12 | -0.62 | -0.69 | -0.5 | -0.59 | -0.36 | -0.48 | -0.46 | -0.63 | -0.39 | -0.33 | -0.43 | -0.44 | -0.6 | -0.76 | -0.59 | -0.51 | -1.28 | -0.62 | -0.81 | -0.41 | -0.44 |
| EBITDA
| -5.188 | -2.695 | -7.684 | -13.608 | -13.02 | -15.158 | -14.705 | -14.545 | -14.86 | -14.583 | -14.431 | -12.175 | -17.459 | -9.542 | -8.387 | -54.544 | 35.915 | -0.419 | -2.661 | -4.216 | -15.194 | 2.72 | -14.816 | -15.585 | -12.078 | -13.983 | -8.514 | -10.827 | -8.29 | -11.094 | -6.858 | -5.597 | -4.955 | -4.758 | -6.399 | -8.058 | -6.286 | -5.365 | -4.477 | -3.56 | -3.381 | -1.742 | -1.006 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,424.167 | -2,476.667 | 0 | 0 | -26.996 | -17,459 | 0 | 0 | 0 | 0 | 0 | 0 | 0.169 | 0 | 0.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |